Disease | neuroendocrine tumor |
Phenotype | C0494165|liver metastasis |
Sentences | 5 |
PubMedID- 23837096 | Four patients are alive with metastatic disease: 1 patient with stable left surrenal and left kidney recurrence 94 months after an enucleation of renal adenocarcinoma metastasis; 1 patient with stable liver metastases 84 months after enucleation and liver metastasectomy of a malignant neuroendocrine tumor associated with synchronous liver metastasis; one patient undergoing laparoscopic jejunal resection for an intraperitoneal recurrence of an unrelated colon adenocarcinoma 33 months after enucleation of renal adenocarcinoma metastasis; the last patient in a terminal stage with diffuse liver metastases 28 months after the enucleation of a malignant neuroendocrine tumor. |
PubMedID- 23558130 | [a case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with s-1/gem combination chemotherapy plus the long-acting somatostatin analogue octreotide]. |
PubMedID- 25693935 | Objective: the objective was to study the clinicopathologic features, grading, treatment protocols, and prognostic of gastroenteropancreatic neuroendocrine tumor (net) with liver metastasis and primary hepatic net. |
PubMedID- 24034980 | liver metastasis of untreated neuroendocrine tumors are usually solid and, to our knowledge, only two cases of neuroendocrine cystic hepatic metastases of ileal atypical carcinoids have been reported so far. |
PubMedID- 24274715 | There is no consensus as to whether or not metastatic nodules in the liver should be biopsied for tumor grading in cases of neuroendocrine tumors with 'synchronous liver metastasis'. |
Page: 1